CHKA and neoplasm: Many CHKα inhibitors such as MN58b, RSM932A, EB-3D and CK37 exhibit potent anti-proliferative effects on cancer cells through induction of apoptosis in vitro and are able to retard tumor growth in mouse xenograft models of human cancers in vivo [1,3,6,20].